Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Cystatin-C and inflammatory markers in the ambulatory elderly.

Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, Siscovick D, Tracy RP, Newman A, Fried L.

Am J Med. 2005 Dec;118(12):1416.

PMID:
16378798
2.

Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status.

Wasén E, Isoaho R, Vahlberg T, Kivelä SL, Irjala K.

Scand J Clin Lab Invest. 2008;68(6):484-91. doi: 10.1080/00365510701854983.

PMID:
18609082
3.

Cystatin C and the risk of death and cardiovascular events among elderly persons.

Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C.

N Engl J Med. 2005 May 19;352(20):2049-60.

4.

Cystatin C and subclinical brain infarction.

Seliger SL, Longstreth WT Jr, Katz R, Manolio T, Fried LF, Shlipak M, Stehman-Breen CO, Newman A, Sarnak M, Gillen DL, Bleyer A, Siscovick DS.

J Am Soc Nephrol. 2005 Dec;16(12):3721-7. Epub 2005 Oct 19.

5.

Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.

Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, Satterfield S, Cummings SR, Newman AB, Fried LF.

J Am Soc Nephrol. 2006 Jan;17(1):254-61. Epub 2005 Nov 2.

6.

Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study.

O'Hare AM, Newman AB, Katz R, Fried LF, Stehman-Breen CO, Seliger SL, Siscovick DS, Shlipak MG.

Arch Intern Med. 2005 Dec 12-26;165(22):2666-70.

PMID:
16344426
7.

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.

Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM.

Circulation. 2003 Jan 7;107(1):87-92.

8.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
9.

Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.

Delaney MP, Stevens PE, Al Hasani M, Stowe HJ, Judge C, Lamb EJ.

Am J Kidney Dis. 2008 Feb;51(2):278-84. doi: 10.1053/j.ajkd.2007.08.018.

PMID:
18215705
10.

Cystatin-C and mortality in elderly persons with heart failure.

Shlipak MG, Katz R, Fried LF, Jenny NS, Stehman-Breen C, Newman AB, Siscovick D, Psaty BM, Sarnak MJ.

J Am Coll Cardiol. 2005 Jan 18;45(2):268-71. Erratum in: J Am Coll Cardiol. 2005 Mar 1;45(5):811.

11.

Cystatin C concentration as a risk factor for heart failure in older adults.

Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG; Cardiovascular Health Study..

Ann Intern Med. 2005 Apr 5;142(7):497-505.

PMID:
15809461
12.

Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study.

Bibbins-Domingo K, Chertow GM, Fried LF, Odden MC, Newman AB, Kritchevsky SB, Harris TB, Satterfield S, Cummings SR, Shlipak MG.

Arch Intern Med. 2006 Jul 10;166(13):1396-402.

PMID:
16832005
13.

GFR estimated from cystatin C versus creatinine in children born small for gestational age.

Franco MC, Nishida SK, Sesso R.

Am J Kidney Dis. 2008 Jun;51(6):925-32. doi: 10.1053/j.ajkd.2008.02.305. Epub 2008 May 2.

PMID:
18455848
14.

Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.

Lee SH, Park SA, Ko SH, Yim HW, Ahn YB, Yoon KH, Cha BY, Son HY, Kwon HS.

Metabolism. 2010 Feb;59(2):241-6. doi: 10.1016/j.metabol.2009.07.019. Epub 2009 Sep 17.

PMID:
19765773
15.

Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.

Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, Chaves P, Furberg C, Kuller L, Newman A.

J Am Soc Nephrol. 2004 Dec;15(12):3184-91.

16.

African ancestry, socioeconomic status, and kidney function in elderly African Americans: a genetic admixture analysis.

Peralta CA, Ziv E, Katz R, Reiner A, Burchard EG, Fried L, Kwok PY, Psaty B, Shlipak M.

J Am Soc Nephrol. 2006 Dec;17(12):3491-6. Epub 2006 Nov 2.

17.

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.

Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S.

Ren Fail. 2008;30(6):625-8. doi: 10.1080/08860220802134607.

PMID:
18661413
18.
19.

Homocysteine or renal impairment: which is the real cardiovascular risk factor?

Potter K, Hankey GJ, Green DJ, Eikelboom JW, Arnolda LF.

Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1158-64. doi: 10.1161/ATVBAHA.108.162743. Epub 2008 Mar 20.

20.

Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods.

Macisaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, Poon A, Jenkins MA, Ratnaike SI, Power DA, Jerums G.

Diabetologia. 2006 Jul;49(7):1686-9. Epub 2006 May 3.

PMID:
16752187

Supplemental Content

Support Center